Everything below concerns lipolysis. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-01-11. Numbers and descriptions here follow the published literature rather than marketing material.
AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.
Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Derived from C-terminal region of human growth hormone |
| Approximate molecular mass | About 1.8 kDa | Varies with sequence length and counterions |
| Confirmed receptor target | None established | No confirmed growth hormone receptor agonism |
| Reported in vitro activity | Lipolysis stimulation and lipogenesis inhibition | Observed mainly in adipocyte models; human relevance uncertain |
| Regulatory status | Not approved as a drug in major markets | May be treated differently across jurisdictions; not a recognized dietary ingredient in some countries |
== Awards == 2005 Hoechst Senior Lecturership in Diabetes by Diamond APICON 2009 Professor P.J. Mehta Oration Award by Association of Physicians of India 2011: Received the Professor Sam G.P. Moses Oration from Research Society for the Study of Diabetes (RSSDI) 2013 Vivian Foncseca Scholar Award from the American Diabetes Association for his research on the link between Diabetes and TB. 2014 Professor Sam. G. P. Moses Oration and Gold Medal Oration from Research Society for the Study of Diabetes (RSSDI) 2014 Dr. B Ramamurthy Endowment Lecture Award, Indian Medical Association Branch 2015 Gold Medal Oration by Research Society for the Study of Diabetes (RSSDI) 2015 Medical Council Award by Governor of Tamil Nadu at Tamil Nadu Medical Council, Chennai 2017 Fellowship Award by Research Society for the Study of Diabetes (RSSDI) 2018 Inspiring Diabetologist of India from Anupriya Patel, Minister of State- Health and Family Welfare Govt of India 2018 Excellence in Diabetic Foot Award from the National Diabetic Foot Conclave 2019 Outstanding Investigator Award from the World-India Diabetes Foundation, a US-based organization in 2019. 2022 Second prize at the 18th European Diabetic Foot Study Group (DFSG) meeting in Bratislava, Slovakia for his research paper submitted on “Improving blood flow and saving the legs of people with Diabetes”
Politico contributed to reinforcing the AI Cold War narrative. In 2020, the paper argued that because of the increasing AI capabilities of China, the US and other democratic countries have to create an alliance to stay ahead of China. Former Google chief executive Eric Schmidt, together with Graham T. Allison alleged in an article in Project Syndicate that, in the context of the COVID-19 pandemic, the AI capabilities of China are ahead of the US in most critical areas. Scientists who have immigrated to the U.S. play an outsize role in the country's development of AI technology. Many of them were educated in China, prompting debates about national security concerns amid worsening relations between the two countries. Policy and technology experts have pointed to concerns about unethical use of AI which would be primarily associated with China. Ethics would therefore constitute a major ideological divide in the upcoming AI Cold War. Fears around disrupting supply chains and a global semiconductor shortage are linked to Taiwan's critical role in the production of semiconductors. 70% of semiconductors are either produced in Taiwan or transfer through Taiwan, where TSMC, world's largest chipmaker is headquartered. The PRC does not recognize the sovereignty of Taiwan and trade restrictions by the US on companies selling semiconductors to the PRC have disrupted in the past the commercial relationships between TSMC and Huawei.
Criminals have been known to dispose of dead bodies by hiding the bodies in trash or landfills, feeding them to animals (such as pigs or rats), industrial processes (e.g., chemical baths), injection into the legitimate body disposal system (such as morgues, funeral homes, cemeteries, crematoriums, funeral pyres or cadaver donations), covert killings at health care facilities, disguising as animal flesh (such as food waste or restaurant food), creating false evidence of the circumstances of death and letting investigators dispose of the body, obscuring the victim's identity, or abandoning the body in a remote area where it can degrade significantly. Animal activity, such as consumption by scavengers, can contaminate the crime scene or destroy evidence before being discovered. However, there are also many instances of gangsters putting the bodies of their victims on display as a form of psychological warfare against their enemies.
Sources: en.wikipedia.org
== France–Switzerland tensions == The location of the summit near the Swiss border led to tensions between France and Switzerland over security costs, border management and the burden placed on Geneva. Swiss officials expressed concern that security risks, demonstrations and part of the cost of the summit would fall on Swiss territory despite Switzerland not being invited as a participant. Swiss President Guy Parmelin wrote to Macron in May 2026 to express concerns about the summit's security implications for Geneva and the wider Lake Geneva region. Geneva officials asked France to host a protest space on French territory, but France refused to do so. The tensions were partly linked to memories of the 29th G8 summit in 2003, when violent anti-globalisation protests in Geneva caused property damage even though the summit itself was held in Évian.
==== Absorption ==== Hydrocodone is only pharmaceutically available as an oral medication. It is well-absorbed, but the oral bioavailability of hydrocodone is only approximately 25%. The onset of action of hydrocodone via this route is 10 to 20 minutes, with a peak effect (Tmax) occurring at 30 to 60 minutes, and it has a duration of 4 to 8 hours. The FDA label for immediate-release hydrocodone with acetaminophen does not include any information on the influence of food on its absorption or other pharmacokinetics. Conversely, coadministration with a high-fat meal increases peak concentrations of different formulations of extended-release hydrocodone by 14 to 54%, whereas area-under-the-curve levels are not notably affected.
Rational protein design techniques must be able to discriminate sequences that will be stable under the target fold from those that would prefer other low-energy competing states. Thus, protein design requires accurate energy functions that can rank and score sequences by how well they fold to the target structure. At the same time, however, these energy functions must consider the computational challenges behind protein design. One of the most challenging requirements for successful design is an energy function that is both accurate and simple for computational calculations. The most accurate energy functions are those based on quantum mechanical simulations. However, such simulations are too slow and typically impractical for protein design. Instead, many protein design algorithms use either physics-based energy functions adapted from molecular mechanics simulation programs, knowledge based energy-functions, or a hybrid mix of both. The trend has been toward using more physics-based potential energy functions. Physics-based energy functions, such as AMBER and CHARMM, are typically derived from quantum mechanical simulations, and experimental data from thermodynamics, crystallography, and spectroscopy. These energy functions typically simplify physical energy function and make them pairwise decomposable, meaning that the total energy of a protein conformation can be calculated by adding the pairwise energy between each atom pair, which makes them attractive for optimization algorithms.
== Physiological significance == ITGA1 is biologically significant because it functions as a key mediator of cell-extracellular matrix (ECM) communication. It's able to regulate interactions with ECM components (collagen and laminin) through the formation of the α1β1 integrin receptor. This influences cell adhesion, migration, survival, proliferation, tissue organization, and intracellular signaling, positioning ITGA1's significance as an important regulator of tissue maintenance, cellular adaptation, and responses to the surrounding microenvironment. The significance of ITGA1 is highly dependent on tissue type, cellular identity, and ECM composition. Although ITGA1 frequently promotes tumor progression in cancers such as PDAC, retinoblastoma, osteosarcoma, and glioma, its biological effects are not universally pro-tumorigenic. In different tissue types, ITGA1 has been observed to exhibit both tumor promoting and tumor suppressive functions. For example, ITGA1 has been reported to influence fibrosis-related pathways and normal tissue remodeling responses. Therefore the significance of ITGA1 depends on the specific biological context in which it is expressed. ITGA1 serves as a critical interface between the extracellular matrix (ECM) and intracellular signaling networks by mediating bidirectional communication between cells and their surrounding microenvironment.
Sources: en.wikipedia.org
AOD9604 is a synthetic peptide based on a C-terminal segment of human growth hormone. It is manufactured by chemical peptide synthesis rather than extracted from human tissue. The sequence is often described as hGH fragment 176–191 or a close variant.
It is not approved as a prescription drug in the United States or the European Union for any indication. Regulatory status can differ by country, and it is often sold as a research chemical or in unapproved products. Such products are not equivalent to an approved medicine.
In the studies reported so far, AOD9604 does not appear to act through the growth hormone receptor and has not shown the typical IGF-1 increase caused by full-length hGH. Human data are limited, so this remains an area of uncertainty. It should not be assumed to have the same effects as hGH.
AOD-9604 is a synthetic peptide fragment of human growth hormone. It corresponds to the C-terminal region known as hGH 176-191 and is studied for metabolic effects. It is not an approved therapeutic drug.